XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Including Additional Paid in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2022 $ 364,974   $ 192,935 $ 205,675   $ (33,636)
Balance (Accounting Standards Update 2018-02 and 2106-01) at Dec. 31, 2022 [1]   $ (4,491)     $ (4,491)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 8,417     8,417    
Other comprehensive income (loss) 4,261         4,261
Cash dividends declared (2,131)     (2,131)    
Repurchased shares of common stock (9,248)   (9,248)      
Excise tax on repurchase of common stock (92)          
Recognition of the fair value of share-based compensation 1,258   1,258      
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units 9   9      
Common stock redeemed for the net settlement of share-based awards (162)   (162)      
Balance at Dec. 31, 2023 362,795   184,700 207,470   (29,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 25,276     25,276    
Other comprehensive income (loss) (3,278)         (3,278)
Cash dividends declared (2,124)     (2,124)    
Repurchased shares of common stock (283)   (283)      
Recognition of the fair value of share-based compensation 1,814   1,814      
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units 5   5      
Common stock redeemed for the net settlement of share-based awards (142)   (142)      
Balance at Dec. 31, 2024 384,063   186,094 230,622 $ (4,500) (32,653)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (35,168)     (35,168)    
Other comprehensive income (loss) 12,523         12,523
Cash dividends declared (2,134)     (2,134)    
Repurchased shares of common stock (521)   (521)      
Recognition of the fair value of share-based compensation 1,221   1,221      
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units 7   7      
Common stock redeemed for the net settlement of share-based awards (224)   (224)      
Balance at Dec. 31, 2025 $ 359,767   $ 186,577 $ 193,320   $ (20,130)
[1]
1 Reflects the impact of adopting Accounting Standards Update (“ASU”) 2016-13.